首页> 外文OA文献 >Association of ATP-Binding Cassette, Sub-family C, Number 2 (ABCC2) Genotype with Pharmacokinetics of Irinotecan in Japanese Patients with Metastatic Colorectal Cancer Treated with Irinotecan Plus Infusional 5-Fluorouracil/Leucovorin (FOLFIRI)

【2h】

Association of ATP-Binding Cassette, Sub-family C, Number 2 (ABCC2) Genotype with Pharmacokinetics of Irinotecan in Japanese Patients with Metastatic Colorectal Cancer Treated with Irinotecan Plus Infusional 5-Fluorouracil/Leucovorin (FOLFIRI)

机译：ATP结合盒，亚家族C，2（ABCC2）基因型与伊替康伊替康加入型5-氟尿嘧啶/ Leucovorin（Folfiri）治疗的日本转移结直肠癌患者的药代动力学

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Ken-ichi Fujita; Fumio Nagashima; Wataru Yamamoto; Hisashi Endo; Yu Sunakawa; Keishi Yamashita; Hiroo Ishida; Keiko Mizuno; Mototsugu Matsunaga; Kazuhiro Araki; Ryuhei Tanaka; Wataru Ichikawa; Toshimichi Miya; Masaru Narabayashi; Yuko Akiyama; Kaori Kawara; Yuichi Ando; Yasutsuna Sasaki;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Association of ATP-Binding Cassette, Sub-family C, Number 2 (ABCC2) Genotype with Pharmacokinetics of Irinotecan in Japanese Patients with Metastatic Colorectal Cancer Treated with Irinotecan Plus Infusional 5-Fluorouracil/Leucovorin (FOLFIRI) [J] . Fujita K, Nagashima F, Yamamoto W, Biological & pharmaceutical bulletin . 2008,第11期

机译：用伊立替康联合输注5-氟尿嘧啶/白叶素治疗的日本转移性结直肠癌患者中，ATP结合盒，C亚家族2（ABCC2）基因型与伊立替康的药代动力学相关性
2. Randomized study of weekly irinotecan plus high-dose 5-fluorouracil (FUIRI) versus biweekly irinotecan plus 5-fluorouracil/leucovorin (FOLFIRI) as first-line chemotherapy for patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors Study [J] . E. Aranda1* M. Valladares2 M. Martinez-Villacampa3 M. Benavides4 A. Gomez1 B. Massutti5 E. Marcuello6 M. Constenla7 J. C. Cámara8 A. Carrato9 R. Dueñas10 M. Reboredo2 M. Navarro3 and E. Díaz-Rubio11 Annals of Oncology . 2009,第2期

机译：每周伊立替康联合大剂量5-氟尿嘧啶（FUIRI）与两周一次伊立替康联合5-氟尿嘧啶/亚叶酸钙（FOLFIRI）作为转移性结直肠癌患者的一线化疗的随机研究：西班牙合作治疗消化道肿瘤研究小组
3. Phase I study of combination therapy with irinotecan, leucovorin, and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for advanced colorectal cancer in Japanese patients. [J] . Yusuke Sasaki, Tetsuya Hamaguchi, Tatsuhiro Arai, Anticancer Research: International Journal of Cancer Research and Treatment . 2014,第4期

机译：I阶段I对日本患者晚期结直肠癌的伊替康，白杨和推注5-氟尿嘧啶（FOLFIRI）的联合治疗研究。
4. Correlation between development of hypertension and efficacy in metastatic colorectal cancer patients treated with bevacizumab [C] . Horinouchi Y., Sakurada T., Nakamura T., European Association for Clinical Pharmacology and Therapeutics . 2011

机译：北伐单抗治疗转移性结直肠癌患者高血压与疗效的相关性
5. Use and outcomes of newer chemotherapeutic agents in colorectal cancer patients using Irinotecan as a case study. [D] . Obeidat, Nour A. 2008

机译：以伊立替康为例的结直肠癌患者中新型化疗药物的使用和结果。
6. A randomized Phase II clinical study of combining panitumumab and bevacizumab plus irinotecan 5-fluorouracil and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for patients with metastatic colorectal cancer and KRAS mutation [O] . Yuguo Liu, Lijuan Luan, Xingli Wang 2015

机译：帕尼单抗和贝伐单抗联合伊立替康5-氟尿嘧啶和亚叶酸钙（FOLFIRI）联合FOLFIRI作为二线治疗转移性结直肠癌和KRAS突变患者的第二阶段随机临床研究
7. CanStem303C trial: A Phase 3 Study of napabucasin (NAPA) in combination with 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI) in adult patients (pts) with previously treated metastatic colorectal cancer (mCRC) - Trial in progress [O] . M. Shah, A. Grothey, N. Tebbutt, 2018

机译：Canstem303C试验：在成年患者（PTS）中与先前治疗的转移性结肠直肠癌（MCRC）的成人患者（PTS）组合的纳帕布桑（NAPA）与5-氟尿嘧啶（5-FU），Leucovorin和Irinotecan（Folfiri）的相结合研究 - 试验

Association of ATP-Binding Cassette, Sub-family C, Number 2 (ABCC2) Genotype with Pharmacokinetics of Irinotecan in Japanese Patients with Metastatic Colorectal Cancer Treated with Irinotecan Plus Infusional 5-Fluorouracil/Leucovorin (FOLFIRI)

著录项

相似文献

相关主题

期刊订阅